2017-2022 Global and Japan Circulating Biomarker Market Analysis Report

August 2017 | 101 pages | ID: 2E47F0C5E0CEN
JP Research

Abstracts

The global Circulating Biomarker market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Circulating Biomarker market's development status and future trend in the global and Japan. It splits Circulating Biomarker market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include

• Biocept Inc (U.S.)
• Myriad Genetics (U.S.)
• QIAGEN (Netherlands)
• Roche (Switzerland)
• Bio-Rad Laboratories (U.S.)
• Trovagene (U.S.)
• Guardant Health (U.S.)
• Janssen Diagnostics (U.S.)
• Fraunhofer-Gesellschaft (Germany)
• MDxHealth SA (U.S.)

Geographically, this report splits the Global market into the following regions:

• Asia Pacific
• Japan
• Tokyo
• Yokohama
• Osaka
• Nagoya
• Others
• China
• Korea
• India
• Others
• Europe
• France
• Germany
• United Kingdom
• Italy
• Russia
• Others
• North America
• United States
• Canada
• Latin America
• Brazil
• Mexico
• Others
• Southeast Asia
• Singapore
• Malaysia
• Vietnam
• Myanmar
• Thailand
• Indonesia
• Philippines
• Others
• Middle East & Africa
• Saudi Arabia
• Iran
• UAE
• Turkey
• Israel
• Egypt
• South Africa
• Others

On the basis of product, the Circulating Biomarker market is primarily split into

By Cancer Type

• Lung
• Breast
• Colorectal
• Prostate

By Product

• Circulating Tumor Cells
• Circulating Tumor DNA

Key Applications

• Reference Laboratory
• Research Centers

Contents

1 CIRCULATING BIOMARKER OVERVIEW

1.1 Product Overview and Scope of Circulating Biomarker
1.2 Global and Japan Circulating Biomarker Market by Applications/End Users
  1.2.1 Japan Circulating Biomarker Sales (K Units) and Market Share Comparison by Applications (2012-2017)
    1.2.1.1 Japan Circulating Biomarker Sales (K Units) and Market Share by Applications (2012-2017)
    1.2.1.2 Japan Circulating Biomarker Sales Growth Rate (%) by Applications (2012-2017)
    1.2.1.3 Market Drivers and Opportunities
  1.2.2 Japan Circulating Biomarker Sales (K Units) and Market Share Comparison by Applications (2012-2017)
  1.2.3 Global Circulating Biomarker Sales by Application (2012-2017)
    1.2.3.1 Global Circulating Biomarker Sales (K Units) and Market Share by Applications (2012-2017)
    1.2.3.2 Global Circulating Biomarker Sales Growth Rate (%) by Applications (2012-2017)
    1.2.3.3 Market Drivers and Opportunities
  1.2.4 Global Circulating Biomarker Sales (K Units) and Market Share Comparison by Applications (2012-2017)
  1.2.5 Reference Laboratory
  1.2.6 Research Centers
1.3 Global and Japan Market Size (Sales and Revenue) of Circulating Biomarker (2012-2017)
  1.3.1 Japan Market Size (Sales and Revenue) of Circulating Biomarker (2012-2017)
    1.3.1.1 Japan Circulating Biomarker Sales (K Units) and Growth Rate (%) (2012-2017)
    1.3.1.2 Japan Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
  1.3.2 Global Market Size (Sales and Revenue) of Circulating Biomarker (2012-2017)
    1.3.2.1 Global Circulating Biomarker Sales (K Units) and Growth Rate (%) (2012-2017)
    1.3.2.2 Global Circulating Biomarker Revenue (Million USD) and Growth Rate (2012-2017)
1.4 Global and Japan Classification of Circulating Biomarker by Cancer Type
  1.4.1 Japan Circulating Biomarker Sales (K Units) and Market Share by Cancer Type (2012-2017)
  1.4.2 Global Circulating Biomarker Sales (K Units) and Market Share by Cancer Type (2012-2017)
  1.4.3 Japan Circulating Biomarker Revenue (Million USD) and Market Share by Cancer Type (2012-2017)
  1.4.4 Global Circulating Biomarker Revenue (Million USD) and Market Share by Cancer Type (2012-2017)
  1.4.5 Japan Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
  1.4.6 Global Circulating Biomarker Price (USD/Unit) by Cancer Type (2012-2017)
  1.4.7 Japan Circulating Biomarker Sales Growth Rate (%) by Cancer Type (2012-2017)
  1.4.8 Global Circulating Biomarker Sales Growth Rate (%) by Cancer Type (2012-2017)
  1.4.9 Lung
  1.4.10 Breast
  1.4.11 Colorectal
  1.4.12 Prostate
1.5 Global and Japan Classification of Circulating Biomarker by Product
  1.5.1 Japan Circulating Biomarker Sales (K Units) and Market Share by Product (2012-2017)
  1.5.2 Global Circulating Biomarker Sales (K Units) and Market Share by Product (2012-2017)
  1.5.3 Japan Circulating Biomarker Revenue (Million USD) and Market Share by Product (2012-2017)
  1.5.4 Global Circulating Biomarker Revenue (Million USD) and Market Share by Product (2012-2017)
  1.5.5 Japan Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
  1.5.6 Global Circulating Biomarker Price (USD/Unit) by Product (2012-2017)
  1.5.7 Japan Circulating Biomarker Sales Growth Rate (%) by Product (2012-2017)
  1.5.8 Global Circulating Biomarker Sales Growth Rate (%) by Product (2012-2017)
  1.5.9 Circulating Tumor Cells
  1.5.10 Circulating Tumor DNA

2 GLOBAL AND JAPAN CIRCULATING BIOMARKER MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Circulating Biomarker Market Competition by Players/Manufacturers
  2.1.1 Japan Circulating Biomarker Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.1.2 Japan Circulating Biomarker Revenue and Share by Players/Manufacturers (2012-2017)
  2.1.3 Japan Circulating Biomarker Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
  2.1.4 Japan Circulating Biomarker Market Competitive Situation and Trends
    2.1.4.1 Japan Circulating Biomarker Market Concentration Rate
    2.1.4.2 Japan Circulating Biomarker Market Share of Top 3 and Top 5 Players/Manufacturers
    2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
  2.1.5 Japan Players/Manufacturers Circulating Biomarker Manufacturing Base Distribution, Sales Area, Product Types
2.2 Global Circulating Biomarker Market Competition by Players/Manufacturers
  2.2.1 Global Circulating Biomarker Sales and Market Share of Key Players/Manufacturers (2012-2017)
  2.2.2 Global Circulating Biomarker Revenue and Share by Players/Manufacturers (2012-2017)
  2.2.3 Global Circulating Biomarker Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
  2.2.4 Global Circulating Biomarker Market Competitive Situation and Trends
    2.2.4.1 Global Circulating Biomarker Market Concentration Rate
    2.2.4.2 Global Circulating Biomarker Market Share of Top 3 and Top 5 Players/Manufacturers
    2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
  2.2.5 Global Players/Manufacturers Circulating Biomarker Manufacturing Base Distribution, Sales Area, Product Types

3 GLOBAL AND JAPAN CIRCULATING BIOMARKER SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Asia Pacific Circulating Biomarker Sales and Revenue by Regions (2012-2017)
  3.1.1 Japan Circulating Biomarker Sales and Revenue (2012-2017)
    3.1.1.1 Japan Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.1.1.2 Japan Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.1.1.3 Japan Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.1.2 China Circulating Biomarker Sales and Revenue (2012-2017)
    3.1.2.1 China Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.1.2.2 China Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.1.2.3 China Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.1.3 Korea Circulating Biomarker Sales and Revenue (2012-2017)
    3.1.3.1 Korea Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.1.3.2 Korea Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.1.3.3 Korea Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.1.4 India Circulating Biomarker Sales and Revenue (2012-2017)
    3.1.4.1 India Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.1.4.2 India Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.1.4.3 India Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.1.5 Others Circulating Biomarker Sales and Revenue (2012-2017)
    3.1.5.1 Others Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.1.5.2 Others Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.1.5.3 Others Circulating Biomarker Price (USD/Unit)(2012-2017)
3.2 Europe Circulating Biomarker Sales and Revenue by Regions (2012-2017)
  3.2.1 France Circulating Biomarker Sales and Revenue (2012-2017)
    3.2.1.1 France Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.2.1.2 France Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.2.1.3 France Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.2.2 Germany Circulating Biomarker Sales and Revenue (2012-2017)
    3.2.2.1 Germany Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.2.2.2 Germany Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.2.2.3 Germany Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.2.3 United Kingdom Circulating Biomarker Sales and Revenue (2012-2017)
    3.2.3.1 United Kingdom Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.2.3.2 United Kingdom Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.2.3.3 United Kingdom Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.2.4 Italy Circulating Biomarker Sales and Revenue (2012-2017)
    3.2.4.1 Italy Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.2.4.2 Italy Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.2.4.3 Italy Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.2.5 Russia Circulating Biomarker Sales and Revenue (2012-2017)
    3.2.5.1 Russia Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.2.5.2 Russia Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.2.5.3 Russia Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.2.6 Others Circulating Biomarker Sales and Revenue (2012-2017)
    3.2.6.1 Others Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.2.6.2 Others Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.2.6.3 Others Circulating Biomarker Price (USD/Unit)(2012-2017)
3.3 North America Circulating Biomarker Sales and Revenue by Regions (2012-2017)
  3.3.1 United States Circulating Biomarker Sales and Revenue (2012-2017)
    3.3.1.1 United States Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.3.1.2 United States Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.3.1.3 United States Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.3.2 Canada Circulating Biomarker Sales and Revenue (2012-2017)
    3.3.2.1 Canada Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.3.2.2 Canada Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.3.2.3 Canada Circulating Biomarker Price (USD/Unit)(2012-2017)
3.4 Latin America Circulating Biomarker Sales and Revenue by Regions (2012-2017)
  3.4.1 Brazil Circulating Biomarker Sales and Revenue (2012-2017)
    3.4.1.1 Brazil Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.4.1.2 Brazil Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.4.1.3 Brazil Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.4.2 Mexico Circulating Biomarker Sales and Revenue (2012-2017)
    3.4.2.1 Mexico Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.4.2.2 Mexico Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.4.2.3 Mexico Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.4.3 Others Circulating Biomarker Sales and Revenue (2012-2017)
    3.4.3.1 Others Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.4.3.2 Others Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.4.3.3 Others Circulating Biomarker Price (USD/Unit)(2012-2017)
3.5 Southeast Asia Circulating Biomarker Sales and Revenue by Regions (2012-2017)
  3.5.1 Singapore Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.1.1 Singapore Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.1.2 Singapore Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.1.3 Singapore Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.2 Malaysia Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.2.1 Malaysia Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.2.2 Malaysia Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.2.3 Malaysia Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.3 Vietnam Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.3.1 Vietnam Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.3.2 Vietnam Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.3.3 Vietnam Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.4 Myanmar Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.4.1 Myanmar Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.4.2 Myanmar Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.4.3 Myanmar Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.5 Thailand Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.5.1 Thailand Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.5.2 Thailand Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.5.3 Thailand Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.6 Indonesia Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.6.1 Indonesia Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.6.2 Indonesia Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.6.3 Indonesia Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.7 Philippines Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.7.1 Philippines Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.7.2 Philippines Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.7.3 Philippines Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.5.8 Others Circulating Biomarker Sales and Revenue (2012-2017)
    3.5.8.1 Others Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.5.8.2 Others Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.5.8.3 Others Circulating Biomarker Price (USD/Unit)(2012-2017)
3.6 Middle East & Africa Circulating Biomarker Sales and Revenue by Regions (2012-2017)
  3.6.1 Saudi Arabia Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.1.1 Saudi Arabia Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.1.2 Saudi Arabia Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.1.3 Saudi Arabia Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.2 Iran Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.2.1 Iran Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.2.2 Iran Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.2.3 Iran Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.3 UAE Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.3.1 UAE Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.3.2 UAE Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.3.3 UAE Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.4 Turkey Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.4.1 Turkey Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.4.2 Turkey Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.4.3 Turkey Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.5 Israel Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.5.1 Israel Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.5.2 Israel Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.5.3 Israel Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.6 Egypt Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.6.1 Egypt Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.6.2 Egypt Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.6.3 Egypt Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.7 South Africa Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.7.1 South Africa Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.7.2 South Africa Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.7.3 South Africa Circulating Biomarker Price (USD/Unit)(2012-2017)
  3.6.8 Others Circulating Biomarker Sales and Revenue (2012-2017)
    3.6.8.1 Others Circulating Biomarker Sales (K Units) and Market Share (2012-2017)
    3.6.8.2 Others Circulating Biomarker Revenue (Million USD) and Market Share (2012-2017)
    3.6.8.3 Others Circulating Biomarker Price (USD/Unit)(2012-2017)

4 GLOBAL AND JAPAN CIRCULATING BIOMARKER PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Biocept Inc (U.S.)
  4.1.1 Company Basic Information, Manufacturing Base and Competitors
  4.1.2 Circulating Biomarker Product Category, Application and Specification
    4.1.2.1 Product A
    4.1.2.2 Product B
  4.1.3 Biocept Inc (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.1.4 Main Business/Business Overview
4.2 Myriad Genetics (U.S.)
  4.2.1 Company Basic Information, Manufacturing Base and Competitors
  4.2.2 Circulating Biomarker Product Category, Application and Specification
    4.2.2.1 Product A
    4.2.2.2 Product B
  4.2.3 Myriad Genetics (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.2.4 Main Business/Business Overview
4.3 QIAGEN (Netherlands)
  4.3.1 Company Basic Information, Manufacturing Base and Competitors
  4.3.2 Circulating Biomarker Product Category, Application and Specification
    4.3.2.1 Product A
    4.3.2.2 Product B
  4.3.3 QIAGEN (Netherlands) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.3.4 Main Business/Business Overview
4.4 Roche (Switzerland)
  4.4.1 Company Basic Information, Manufacturing Base and Competitors
  4.4.2 Circulating Biomarker Product Category, Application and Specification
    4.4.2.1 Product A
    4.4.2.2 Product B
  4.4.3 Roche (Switzerland) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.4.4 Main Business/Business Overview
4.5 Bio-Rad Laboratories (U.S.)
  4.5.1 Company Basic Information, Manufacturing Base and Competitors
  4.5.2 Circulating Biomarker Product Category, Application and Specification
    4.5.2.1 Product A
    4.5.2.2 Product B
  4.5.3 Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.5.4 Main Business/Business Overview
4.6 Trovagene (U.S.)
  4.6.1 Company Basic Information, Manufacturing Base and Competitors
  4.6.2 Circulating Biomarker Product Category, Application and Specification
    4.6.2.1 Product A
    4.6.2.2 Product B
  4.6.3 Trovagene (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.6.4 Main Business/Business Overview
4.7 Guardant Health (U.S.)
  4.7.1 Company Basic Information, Manufacturing Base and Competitors
  4.7.2 Circulating Biomarker Product Category, Application and Specification
    4.7.2.1 Product A
    4.7.2.2 Product B
  4.7.3 Guardant Health (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.7.4 Main Business/Business Overview
4.8 Janssen Diagnostics (U.S.)
  4.8.1 Company Basic Information, Manufacturing Base and Competitors
  4.8.2 Circulating Biomarker Product Category, Application and Specification
    4.8.2.1 Product A
    4.8.2.2 Product B
  4.8.3 Janssen Diagnostics (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.8.4 Main Business/Business Overview
4.9 Fraunhofer-Gesellschaft (Germany)
  4.9.1 Company Basic Information, Manufacturing Base and Competitors
  4.9.2 Circulating Biomarker Product Category, Application and Specification
    4.9.2.1 Product A
    4.9.2.2 Product B
  4.9.3 Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.9.4 Main Business/Business Overview
4.10 MDxHealth SA (U.S.)
  4.10.1 Company Basic Information, Manufacturing Base and Competitors
  4.10.2 Circulating Biomarker Product Category, Application and Specification
    4.10.2.1 Product A
    4.10.2.2 Product B
  4.10.3 MDxHealth SA (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  4.10.4 Main Business/Business Overview

5 CIRCULATING BIOMARKER MANUFACTURING COST ANALYSIS

5.1 Circulating Biomarker Key Raw Materials Analysis
  5.1.1 Key Raw Materials
  5.1.2 Price Trend of Key Raw Materials
  5.1.3 Key Suppliers of Raw Materials
  5.1.4 Market Concentration Rate of Raw Materials
5.2 Proportion of Manufacturing Cost Structure
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Manufacturing Expenses
5.3 Manufacturing Process Analysis of Circulating Biomarker

6 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

6.1 Circulating Biomarker Industrial Chain Analysis
6.2 Upstream Raw Materials Sourcing
6.3 Raw Materials Sources of Circulating Biomarker Major Players/Manufacturers in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Marketing Channel
  7.1.1 Direct Marketing
  7.1.2 Indirect Marketing
  7.1.3 Marketing Channel Development Trend
7.2 Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Distributors/Traders List

8 MARKET EFFECT FACTORS ANALYSIS

8.1 Technology Progress/Risk
  8.1.1 Substitutes Threat
  8.1.2 Technology Progress in Related Industry
8.2 Consumer Needs/Customer Preference Change
8.3 Economic/Political Environmental Change

9 GLOBAL AND JAPAN CIRCULATING BIOMARKER MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

9.1 Global and Japan Circulating Biomarker Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
9.2 Global and Japan Circulating Biomarker Sales (K Units) Forecast by Type (2017-2022)
  9.2.1 by Cancer Type
  9.2.2 by Product
9.3 Global and Japan Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
9.4 Global and Japan Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 METHODOLOGY AND DATA SOURCE

11.1 Methodology/Research Approach
  11.1.1 Research Programs/Design
  11.1.2 Market Size Estimation
  11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
  11.2.1 Secondary Sources
  11.2.2 Primary Sources
11.3 Disclaimer
11.4 Author List

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Circulating Biomarker
Table Japan Circulating Biomarker Sales (Million Units) Comparison by Applications (2012-2017)
Figure Japan Sales Market Share (%) of Circulating Biomarker by Applications in 2016
Table Global Circulating Biomarker Sales (Million Units) Comparison by Applications (2012-2017)
Figure Global Sales Market Share (%) of Circulating Biomarker by Applications in 2016
Figure Reference Laboratory Examples
Table Key Downstream Customer in Reference Laboratory
Figure Research Centers Examples
Table Key Downstream Customer in Research Centers
Figure Lung Product Picture
Figure Breast Product Picture
Figure Colorectal Product Picture
Figure Prostate Product Picture
Figure Circulating Tumor Cells Product Picture
Figure Circulating Tumor DNA Product Picture
Table Biocept Inc (U.S.) Basic Information List
Table Biocept Inc (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Biocept Inc (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Biocept Inc (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Biocept Inc (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Myriad Genetics (U.S.) Basic Information List
Table Myriad Genetics (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Myriad Genetics (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Myriad Genetics (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Myriad Genetics (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table QIAGEN (Netherlands) Basic Information List
Table QIAGEN (Netherlands) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table QIAGEN (Netherlands) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table QIAGEN (Netherlands) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure QIAGEN (Netherlands) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Roche (Switzerland) Basic Information List
Table Roche (Switzerland) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Roche (Switzerland) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Roche (Switzerland) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Roche (Switzerland) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Bio-Rad Laboratories (U.S.) Basic Information List
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Bio-Rad Laboratories (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Bio-Rad Laboratories (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Trovagene (U.S.) Basic Information List
Table Trovagene (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Trovagene (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Trovagene (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Trovagene (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Guardant Health (U.S.) Basic Information List
Table Guardant Health (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Guardant Health (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Guardant Health (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Guardant Health (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Janssen Diagnostics (U.S.) Basic Information List
Table Janssen Diagnostics (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Janssen Diagnostics (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Janssen Diagnostics (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Janssen Diagnostics (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Basic Information List
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure Fraunhofer-Gesellschaft (Germany) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table MDxHealth SA (U.S.) Basic Information List
Table MDxHealth SA (U.S.) Circulating Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Table MDxHealth SA (U.S.) Circulating Biomarker Sales Growth Rate (%)(2012-2017)
Table MDxHealth SA (U.S.) Circulating Biomarker Sales Market Share (%) in Japan (2012-2017)
Figure MDxHealth SA (U.S.) Circulating Biomarker Revenue Market Share (%) in Japan (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Circulating Biomarker
Figure Manufacturing Process Analysis of Circulating Biomarker
Figure Circulating Biomarker Industrial Chain Analysis
Table Raw Materials Sources of Circulating Biomarker Major Players/Manufacturers in 2016
Table Major Buyers of Circulating Biomarker
Table Distributors/Traders List
Figure Japan Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Japan Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Circulating Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Circulating Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table Japan Circulating Biomarker Sales (K Units) Forecast by Type (2017-2022)
Table Global Circulating Biomarker Sales (K Units) Forecast by Type (2017-2022)
Figure Japan Circulating Biomarker Sales (K Units) Forecast by Type (2017-2022)
Figure Global Circulating Biomarker Sales (K Units) Forecast by Type (2017-2022)
Figure Japan Circulating Biomarker Sales Volume Market Share Forecast by Type in 2017
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Type in 2017
Table Japan Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure Japan Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Circulating Biomarker Sales Volume Market Share Forecast by Application in 2017
Table Global Circulating Biomarker Sales (K Units) Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Circulating Biomarker Sales Volume Market Share Forecast by Application in 2017
Table Japan Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table Japan Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Table Global Circulating Biomarker Sales (K Units) Forecast by Regions (2017-2022)
Table Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Circulating Biomarker Sales Volume Share Forecast by Regions (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources